{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:25:43Z","timestamp":1782818743922,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020707","name":"Janssen Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ajp.2025.104455","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T02:05:26Z","timestamp":1742695526000},"page":"104455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Budget impact analysis of long-acting injections for the treatment of Schizophrenia in Japan"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0170-1442","authenticated-orcid":false,"given":"Mami","family":"Kasahara-Kiritani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-chu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameet","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayooj Sunil","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataru","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12888-022-04044-5","article-title":"Burden of schizophrenia among Japanese patients: a cross-sectional National Health and Wellness Survey","volume":"22","author":"Baba","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/wps.21036","article-title":"Metabolic side effects in persons with schizophrenia during mid-to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials","volume":"22","author":"Burschinski","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ajp.2025.104455_bib3","first-page":"357","article-title":"Global economic burden of schizophrenia: a systematic review","volume":"12","author":"Chong","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"key":"10.1016\/j.ajp.2025.104455_bib4","unstructured":"City of Yokohama, 2023. \u969c\u5bb3\u306e\u3042\u308b\u65b9\u3078\u306e\u652f\u63f4\u306a\u3069 [Support for people with disabilities, etc.], \u3008https:\/\/www.city.yokohama.lg.jp\/lang\/residents\/en\/welfare\/support.html\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/NDT.S113099","article-title":"Antipsychotic-associated weight gain: management strategies and impact on treatment adherence","author":"Dayabandara","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2025.104455_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-244X-12-20","article-title":"A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia","volume":"12","author":"Dibonaventura","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00019053-200725010-00002","article-title":"Rates and probabilities in economic modelling: transformation, translation and appropriate application","volume":"25","author":"Fleurence","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/15622975.2012.739708","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects","volume":"14","author":"Hasan","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104455_bib9","unstructured":"IQVIA Japan, Domestic Data Services, \u3008https:\/\/www.iqvia.com\/ja-jp\/locations\/japan\/solutions-and-services\/market-data\/domestic-market-data\u3009."},{"issue":"3","key":"10.1016\/j.ajp.2025.104455_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese Society of Neuropsychopharmacology: \"Guideline for Pharmacological Therapy of Schizophrenia\"","volume":"41","author":"JSNP","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"4","key":"10.1016\/j.ajp.2025.104455_bib11","doi-asserted-by":"crossref","DOI":"10.15270\/52-4-526","article-title":"Japanese mental health care in historical context: why did Japan become a country with so many psychiatric care beds?","volume":"52","author":"Kanata","year":"2016","journal-title":"Soc. Work"},{"issue":"8","key":"10.1016\/j.ajp.2025.104455_bib12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/13696998.2020.1754229","article-title":"Budget impact analysis of long acting injection for schizophrenia in Japan","volume":"23","author":"Kasahara-Kiritani","year":"2020","journal-title":"J. Med Econ."},{"key":"10.1016\/j.ajp.2025.104455_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103671","article-title":"Clinical benefit of second-generation long-acting injectable antipsychotics in preventing re-hospitalization in patients with schizophrenia: a real-world study in Japan","volume":"86","author":"Kasahara-Kiritani","year":"2023","journal-title":"Asian J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12888-022-03846-x","article-title":"Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey","volume":"22","author":"Keenan","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12991-019-0254-2","article-title":"Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia","volume":"19","author":"Kim","year":"2020","journal-title":"Ann. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2025.104455_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ajp.2025.104455_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103476","article-title":"Free long-acting injectables for patients with psychosis: a step forward","volume":"83","author":"Kong","year":"2023","journal-title":"Asian J. Psychiatr."},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgab030","article-title":"Inpatient treatment of people with schizophrenia: quantifying clinical change using the health of the nation outcome scales","volume":"2","author":"Lay","year":"2021","journal-title":"Schizophr. Bull. Open"},{"issue":"3","key":"10.1016\/j.ajp.2025.104455_bib19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.9758\/cpn.2020.18.3.386","article-title":"Korean Medication Algorithm for Schizophrenia 2019, second revision: treatment of psychotic symptoms","volume":"18","author":"Lee","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.ajp.2025.104455_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221079165","article-title":"Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics","volume":"12","author":"Lin","year":"2022","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2025.104455_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221079165","article-title":"Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics","volume":"12","author":"Lin","year":"2022","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2025.104455_bib22","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2147\/NDT.S413371","article-title":"Long-acting injectable antipsychotic treatment for Schizophrenia in Asian population: a scoping review","volume":"19","author":"Ma","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2025.104455_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/CEOR.S85514","article-title":"Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan","author":"Mahlich","year":"2015","journal-title":"Clin. Outcomes Res."},{"issue":"4","key":"10.1016\/j.ajp.2025.104455_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250771","article-title":"Structure and predictors of in-hospital nursing care leading to reduction in early readmission among patients with schizophrenia in Japan: A cross-sectional study","volume":"16","author":"Maki","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1176\/appi.ajp.20230922","article-title":"Psychotropic drug-related weight gain and its treatment","volume":"181","author":"McIntyre","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104455_bib26","unstructured":"MHLW, 2010. About Independence Support Medical Care (psychiatric outpatient medical care) \u3008https:\/\/www.mhlw.go.jp\/seisakunitsuite\/bunya\/hukushi_kaigo\/shougaishahukushi\/jiritsu\/dl\/03.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib27","unstructured":"MHLW, 2011. [9] Health Care and Welfare Measures for Persons with Disabilities, \u3008https:\/\/www.mhlw.go.jp\/english\/wp\/wp-hw6\/dl\/09e.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib28","unstructured":"MHLW, 2015. [2] Health and Medical Services, \u3008https:\/\/www.mhlw.go.jp\/english\/wp\/wp-hw9\/dl\/02e.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib29","unstructured":"MHLW, 2017. \u5e73\u6210 29 \u5e74 \u60a3 \u8005 \u8abf \u67fb \u306e \u6982 \u6cc1 [2017 Overview of patient survey], \u3008https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/kanja\/17\/dl\/kanja.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib30","unstructured":"MHLW, 2018. \u81ea\u7acb\u652f\u63f4\u533b\u7642\uff08\u7cbe\u795e\u901a\u9662\u533b\u7642\uff09\u306b\u3064\u3044\u3066 [About medical support for persons with disabilities (outpatient psychiatric care)], \u3008https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-12200000-Shakaiengokyokushougaihokenfukushibu\/0000146932.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib31","unstructured":"MHLW, 2019. \u4e3b\u306a\u50b7\u75c5\u306e\u7dcf\u60a3\u8005\u6570 [Total number of patients with major injuries and illnesses], \u3008https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/kanja\/17\/dl\/05.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib32","unstructured":"MHLW, 2020a. Part 8 Psychiatric Specialized Therapy, \u3008https:\/\/www.mhlw.go.jp\/content\/12400000\/000603759.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib33","unstructured":"MHLW, 2020b. Partial revision of facility standards for basic medical fees, Ministry of Health, Labor and Welfare Notification No. 58, \u3008https:\/\/www.mhlw.go.jp\/content\/12400000\/000602943.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib34","unstructured":"MHLW, 2020c. \u4ee4\u548c\uff12\u5e74\u5ea6\u8a3a\u7642\u5831\u916c\u6539\u5b9a\u306e\u6982\u8981\uff08\u7cbe\u795e\u533b\u7642\uff09[Overview of FY2020 Revision of Medical Fees (Pyschiatric Medical Care)], \u3008https:\/\/www.mhlw.go.jp\/content\/12400000\/000608535.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib35","unstructured":"MHLW, 2020d. \u533b\u79d1\u8a3a\u7642\u5831\u916c\u70b9\u6570\u8868\u306b\u95a2\u3059\u308b\u4e8b\u9805 [Regarding implementation considerations due to partial revision of medical fee calculation method (Notice) >March 4, 2020 Health Insurance Issue 0304 No. 1 >Attachment 1 (Medical score table)], \u3008https:\/\/www.mhlw.go.jp\/content\/12404000\/000984041.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib36","unstructured":"MHLW, 2024a. Appendix 1-1 Medical Treatment Fee Schedule, \u3008https:\/\/www.mhlw.go.jp\/content\/12404000\/001209396.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib37","unstructured":"MHLW, 2024b. Notification of Medical Practice and Notification Information Statement, \u3008https:\/\/shinryohoshu.mhlw.go.jp\/shinryohoshu\/paMenu\/doPaDetailSpNext&100\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib38","unstructured":"MHLW, 2024c. \u85ac\u4fa1\u57fa\u6e96\u53ce\u8f09\u54c1\u76ee\u30ea\u30b9\u30c8\u53ca\u3073\u5f8c\u767a\u533b\u85ac\u54c1\u306b\u95a2\u3059\u308b\u60c5\u5831\u306b\u3064\u3044\u3066[Regarding the Drug Price List and Information on Generic Drugs (effective April 1, 2024)], \u3008https:\/\/www.mhlw.go.jp\/topics\/2024\/04\/tp20240401-01.html\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.schres.2021.02.016","article-title":"Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: analyses based on a spontaneous reporting system database in Japan","volume":"231","author":"Misawa","year":"2021","journal-title":"Schizophr. Res"},{"issue":"2","key":"10.1016\/j.ajp.2025.104455_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/challe13020038","article-title":"Community-based integrated care system for people with mental illness in Japan: evaluating location characteristics of group homes to determine the feasibility of daily life skill training","volume":"13","author":"Nagayama","year":"2022","journal-title":"Challenges"},{"issue":"2","key":"10.1016\/j.ajp.2025.104455_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40120-019-0147-y","article-title":"Modeling the choice between risperidone long-acting injectable and generic risperidone from the perspective of a japanese hospital","volume":"8","author":"Nakamura","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ajp.2025.104455_bib42","unstructured":"NCNP, 2019. \u63aa\u7f6e\u5165\u9662\u8005\u306e\u5b9f\u614b\u628a\u63e1\u3068\u5fc5\u8981\u306a\u533b\u7642\u5bc6\u5ea6\u306b\u95a2\u3059\u308b\u7814\u7a76 \u305d\u306e\uff11\uff08\uff11\uff09 \u63aa\u7f6e\u5165\u9662\u3068\u306a\u3063\u305f\u7cbe\u795e\u969c\u5bb3\u8005\u306e\u6cbb\u7642\u8ee2\u5e30\u306b\u95a2\u3059\u308b\u524d\u5411\u304d \u30b3\u30db\u30fc\u30c8\u7814\u7a76\uff1a\u63aa\u7f6e\u5165\u9662\u4e2d\u306e\u7cbe\u795e\u969c\u5bb3\u8005\u306e\u793e\u4f1a\u6a5f\u80fd\u306b\u95a2\u3059\u308b\u691c\u8a0e [Research on the actual situation of involuntary hospitalization and the necessary medical density Part 1 (1) Prospective cohort study on the treatment outcome of involuntary hospitalization of mentally disabled persons: Examination of the social functioning of involuntary hospitalization of mentally disabled persons], \u3008https:\/\/www.ncnp.go.jp\/nimh\/chiiki\/documents\/r20-28.pdf\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib43","unstructured":"NCNP, 2024. \u7cbe\u795e\u4fdd\u5065\u798f\u7949\u8cc7\u6599 [Mental health and welfare resources], \u3008https:\/\/www.ncnp.go.jp\/nimh\/seisaku\/data\/630.html\u3009."},{"issue":"3","key":"10.1016\/j.ajp.2025.104455_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejpsy.2022.01.002","article-title":"The association of metabolic syndrome and long acting injectable antipsychotics: a systematic review","volume":"36","author":"Nguyen","year":"2022","journal-title":"Eur. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104455_bib45","unstructured":"OECD, 2024. OECD Data Explorer, \u3008https:\/\/data-explorer.oecd.org\/vis?tm=Japan%20psychiatric%20beds&pg=\u20090&snb=\u20092&vw=tb&df\u3009[ds]=dsDisseminateFinalDMZ&df[id]=DSD_HEALTH_REAC_HOSP%40DF_BEDS_FUNC&df[ag]=OECD.ELS.HD&df[vs]=\u20091.0&dq=\u2009.10P3HB\u2026.PSY%2B_T.&pd=\u20092015%2C&to[TIME_PERIOD]=false."},{"issue":"2","key":"10.1016\/j.ajp.2025.104455_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/npr2.12435","article-title":"Barriers to long-acting injectable atypical antipsychotic use in Japan: insights from a comparative psychiatrist survey","volume":"44","author":"Oguchi","year":"2024","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.ajp.2025.104455_bib47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.psychres.2018.10.020","article-title":"Timely follow-up visits after psychiatric hospitalization and readmission in schizophrenia and bipolar disorder in Japan","volume":"270","author":"Okumura","year":"2018","journal-title":"Psychiatry Res"},{"issue":"8","key":"10.1016\/j.ajp.2025.104455_bib48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2188\/jea.JE20180096","article-title":"Psychiatric admissions and length of stay during fiscal years 2014 and 2015 in Japan: a retrospective cohort study using a nationwide claims database","volume":"29","author":"Okumura","year":"2019","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.ajp.2025.104455_bib49","unstructured":"PMDA, 2024. Ethical Drugs Package Inserts Information Search, \u3008https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuSearch\/\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.schres.2022.11.018","article-title":"Weight changes in people with early psychosis treated with oral or long-acting injectable aripiprazole","volume":"251","author":"Shymko","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2025.104455_bib51","unstructured":"Statistics Bureau of Japan, 2018. Result of the Population Estimates, \u3008https:\/\/www.stat.go.jp\/english\/data\/jinsui\/2.html\u3009."},{"key":"10.1016\/j.ajp.2025.104455_bib52","volume":"2023","author":"Statistics Bureau of Japan","year":"2023"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib53","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MS21078COM5","article-title":"The epidemiology and global burden of Schizophrenia","volume":"84","author":"Velligan","year":"2023","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib54","doi-asserted-by":"crossref","first-page":"38864","DOI":"10.4088\/JCP.20m13850","article-title":"Persistence with and adherence to paliperidone palmitate once-monthly injection for schizophrenia treatment in China and Japan","volume":"83","author":"Wang","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104455_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2020.07.007","article-title":"Non-psychiatric hospitalization length-of-stay for patients with psychotic disorders: a mixed methods study","volume":"67","author":"Weissinger","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104455_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.13374","article-title":"Guidance on the clinical understanding and use of long-acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements","volume":"27","author":"Wong","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.ajp.2025.104455_bib57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40263-020-00713-9","article-title":"Adherence to oral antipsychotics measured by electronic adherence monitoring in schizophrenia: a systematic review and meta-analysis","volume":"34","author":"Yaegashi","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2025.104455_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103789","article-title":"Comparison of health resource usage and costs associated with first-generation and second-generation long-acting injectable antipsychotics for patients with schizophrenia: a nationwide population-based cohort study","volume":"89","author":"Yang","year":"2023","journal-title":"Asian J. Psychiatr."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187620182500098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187620182500098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:49:56Z","timestamp":1746114596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187620182500098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":58,"alternative-id":["S187620182500098X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104455","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Budget impact analysis of long-acting injections for the treatment of Schizophrenia in Japan","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104455"}}